skip to main content

April 22, 2024 – November 25, 2024


Optimizing Medication Safety in Primary Care & Outpatient Settings: An Interactive Series

Accreditation


Course Directors

Anas Hamad, PhD; Phyllis Muffuh Navti, DHSci.

  • Have no relevant financial/non-financial relationships with any for-profit/not-for-profit organizations to disclose.
  • Will not be discussing unlabeled/unapproved use of drugs or products.
      

Course Faculty

Anas Hamad, PhD; Phyllis Muffuh Navti, DHSci; Reham Negmeldin, MD; Ayat Kadhi, MSc; Vyas Saseendran, PhD; Alla El- Awaisi, PhD, Manal Al-Zaidan, PharmD; Ahmed Awaisu, BPharm, MPharm, PhD; Vaqas Rashid, MBBS; Andrew MacDonald, MS; Kelby Bottoman, MPH; Mai Mahmoud, MBBS; Thabit T. Melhem, MSN; Ebtesam Abdulla, MSN; Abdul Rouf Palli Valapila, PhD; Yasir Tarabichi, MD; Ahmed Makhlouf, PhD

  • Have no relevant financial/non-financial relationships with any for-profit/not-for-profit organizations to disclose.
  • Will not be discussing unlabeled/unapproved use of drugs or products.
      

Scientific Planning Committee

Mai Mahmoud, MD; Vyas Saseendran Kattezhathu, PhD; Ayat Kadhi, MSc; Andrew MacDonald, MSc; Ziana Vamanjoor, BDS

  • Have no relevant financial/non-financial relationships with any for-profit/not-for-profit organizations to disclose.
  • Will not be discussing unlabeled/unapproved use of drugs or products.
     

Course Administrator

Ameena M. Abdul Rahim, MSc

  • Have no relevant financial/non-financial relationships with any for-profit/not-for-profit organizations to disclose.
  • Will not be discussing unlabeled/unapproved use of drugs or products.


Disclosure of Relationships/Content Validity

It is the policy of Weill Cornell Medicine-Qatar to adhere to Ministry of Public Health's Department of Healthcare Professions (DHP) and Accreditation Council for Continuing Medical Education (ACCME) Criteria, Policies, and Standards for Commercial Support and content validation in order to ensure fair balance, independence, objectivity, and scientific rigor in all its sponsored programs. All faculty participating in sponsored programs are expected to disclose relevant financial relationships pertaining to their contribution to the activity, and any discussions of off-label or investigational uses of approved commercial products or devices, or of any products or devices not yet approved in the United States and elsewhere. WCM-Q CME/CPD activities are intended to be evidence-based and free of commercial bias. 


Evaluation

An anonymous evaluation will be conducted online and can be found in your “My CE” tab of the WCM-Q CloudCME portal (https://wcmq.cloud-cme.com). All participants are required to complete the evaluation in order to qualify for a certificate.The evaluation allows us to assess the degree to which the activity met its objectives.It will also guide the planning of future activities and inform decisions about improving the educational program.


Accreditation and Credit Designation

Accreditation Council for Continuing Medical Education (ACCME)

The Weill Cornell Medicine-Qatar is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The Weill Cornell Medicine-Qatar designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

 

Weill Cornell Medicine-Qatar is accredited as a provider of Continuing Medical Education (CME) and Continuing Professional Development (CPD) by the Department of Healthcare Professions of the Ministry of Public Health.

This activity is an Accredited Group Learning Activity (Category 1) as defined by the Ministry of Public Health's Department of Healthcare Professions-Accreditation Section and is approved for a maximum of 1.5 hours.

The scientific planning committee has reviewed all disclosed financial relationships of speakers, moderators, facilitators and/or authors in advance of this CPD activity and has implemented procedures to manage any potential or real conflicts of interest.